Virtual Therapeutics for MCI - Trial NCT06079411
Access comprehensive clinical trial information for NCT06079411 through Pure Global AI's free database. This phase not specified trial is sponsored by Istituto Auxologico Italiano and is currently Not yet recruiting. The study focuses on Mild Cognitive Impairment. Target enrollment is 36 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Istituto Auxologico Italiano
Timeline & Enrollment
N/A
Oct 01, 2023
Jul 01, 2026
Primary Outcome
The long-term visuospatial memory scores from Corsi supra span,the spatial rotation score from the Manikin Test
Summary
Mild Cognitive Impairment (MCI) is a term used to describe the transitional stage that occurs
 between normal aging and the onset of dementia. Spatial disorientation is often considered a
 significant indicator for diagnosing dementia. Numerous studies have documented deficits in
 both the allocentric and egocentric spatial frames of reference, as well as difficulties in
 transitioning between them, in individuals with MCI. Rapid advances in computing technology
 have enabled researchers to conduct cognitive training and rehabilitation interventions with
 the assistance of technology. Therefore, the aim of the study is to use virtual therapeutics
 to train MCI spatial memory.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06079411
Device Trial